Vision Financial Markets LLC Novo Cure LTD Transaction History
Vision Financial Markets LLC
- $106 Billion
- Q2 2025
A detailed history of Vision Financial Markets LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Vision Financial Markets LLC holds 50 shares of NVCR stock, worth $556. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 50
-0.0%
Holding current value
$556
Previous $891,000
0.11%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NVCR
# of Institutions
264Shares Held
79.1MCall Options Held
970KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$135 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$120 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$99.6 Million0.03% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$61.5 Million8.14% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$58 Million0.02% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.17B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...